APA (7th ed.) Citation

Gärtner, J., Hauser, S. L., Bar-Or, A., Montalban, X., Cohen, J. A., Cross, A. H., . . . Kappos, L. (2022). Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II. Multiple sclerosis, 28(10), 13524585221078825. https://doi.org/10.1177/13524585221078825

Chicago Style (17th ed.) Citation

Gärtner, Jutta, et al. "Efficacy and Safety of Ofatumumab in Recently Diagnosed, Treatment-naive Patients with Multiple Sclerosis: Results from ASCLEPIOS I and II." Multiple Sclerosis 28, no. 10 (2022): 13524585221078825. https://doi.org/10.1177/13524585221078825.

MLA (9th ed.) Citation

Gärtner, Jutta, et al. "Efficacy and Safety of Ofatumumab in Recently Diagnosed, Treatment-naive Patients with Multiple Sclerosis: Results from ASCLEPIOS I and II." Multiple Sclerosis, vol. 28, no. 10, 2022, p. 13524585221078825, https://doi.org/10.1177/13524585221078825.